SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (236)11/24/1997 1:17:00 AM
From: chirodoc   of 569
 
<<<<<<You and Tom D. have done a great job getting out
the DEPO story .....

.......i agree

.......assuming they get approval though--what is the encore?

.......if i can snag some profits in depo, my plan was to plow some of them into biox. as i have mentioned, there are hundreds of thousands of knees out there with O/A that could benefit and the alternative, nsaid's, are rot gut.

.......i'll mention this to him after he has become wealthy from depo.

........btw, do you really think it is a slam dunk? it does seem likely since cytarabine (their chemo in lipid sandwich) has been around for a while and is used commonly. also, it appears that dosing is steadier with the lipid matrix around the chemo core. i hope you are right.

........but i think that we have a winner here in biox if they can just market the hell out of it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext